|1|Confirmation of the reported association of clonal chromosomal mosaicism with an increased risk of incident hematologic cancer. (23533652)
Schick U.M.... Carlson C.S.
|2|Internet-based program for coping with cancer: a randomized controlled trial with hematologic cancer patients. (22565413)
David N.... Larbig W.
|3|Xist RNA is a potent suppressor of hematologic cancer in mice. (23415223)
Yildirim E.... Lee J.T.
|4|Refining the UGT1A haplotype associated with irinotecan-induced hematological toxicity in metastatic colorectal cancer patients treated with 5-fluorouracil/irinotecan-based regimens. (23386248)
LAcvesque E.... Guillemette C.
|5|Evaluation of MycAssaya8c Aspergillus for diagnosis of invasive pulmonary aspergillosis in patients without hematological cancer. (23620764)
Guinea J.... Bouza E.
|6|Pharmacokinetics of piperacillin/tazobactam in cancer patients with hematological malignancies and febrile neutropenia after chemotherapy. (24286231)
A8lvarez J.C.... CortAcs J.A.
|7|Targeting p53 in vivo: a first-in-human study with p53-targeting compound APR-246 in refractory hematologic malignancies and prostate cancer. (22965953)
Lehmann S.... Andersson P.O.
|8|Thymidylate synthase polymorphisms and hematological cancer risk: a meta-analysis. (22166040)
Weng Y.... Chen G.
|9|Family history of non-hematologic cancers among Waldenstrom macroglobulinemia patients: a preliminary study. (22099500)
Ojha R.P.... Treon S.P.
|10|A stapled BIM peptide overcomes apoptotic resistance in hematologic cancers. (22622039)
Labelle J.L.... Walensky L.D.
|11|Febrile neutropenia incidence and hematological toxicity with the FEC100-docetaxel regimen in the treatment of early-stage breast cancer. (22713627)
Cousin S.... Bonneterre J.
|12|p53 codon 72 polymorphism and hematological cancer risk: an update meta-analysis. (23029260)
Weng Y.... Zhang J.
|13|A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy. (22293537)
Kiyotani K.... Zembutsu H.
|14|Improving access to information and support for patients with less common cancers: hematologic cancer patients' views about Web-based approaches. (22189354)
Paul C.L.... Henskens F.A.
|15|Physical activity and hematologic cancer prevention. (21113763)
Pan S.Y.... Morrison H.
|16|Impact of influenza A(H1N1) in pediatric patients with cancer and hematologic disorders: establishment of information sharing system for swine influenza. (22185798)
Ota S.... Tsuchida M.
|17|Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009. (20138081)
Campo M.... Kontoyiannis D.P.
|18|Mesial temporal sclerosis as a complication of hematologic cancer. (19434437)
Sivera R.... Villanueva V.
|19|Managed care considerations: hematologic cancer as a chronic disease. (19119536)
|20|Phase 3 trials suggest ways to improve current hematologic cancer therapies. (18252877)
|21|Femoral resurfacing in young patients with hematologic cancer and osteonecrosis. (18679763)
Karimova E.J.... Neel M.D.
|22|Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. (18344563)
Meirow D.... Ben Yehuda D.
|23|Posaconazole prophylaxis in hematologic cancer. (17526090)
Kontoyiannis D.P.... Lewis R.E.
|24|A yeast two-hybrid system using Sp17 identified ropporin as a novel cancer-testis antigen in hematologic malignancies. (17551920)
Li Z.... Lim S.H.
|25|Wheat grass juice may improve hematological toxicity related to chemotherapy in breast cancer patients: a pilot study. (17571966)
Bar-Sela G.... Goldberg H.
|26|The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers. (17683622)
|27|Posaconazole prophylaxis in hematologic cancer. (17522407)
Weiler S.... Bellmann R.
|28|Posaconazole prophylaxis in hematologic cancer. (17526091)
|29|Serum Aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis: a study of 56 patients with hematologic cancer. (17607669)
Woods G.... Anaissie E.
|30|Low mannose-binding lectin concentration is associated with severe infection in patients with hematological cancer who are undergoing chemotherapy. (17516403)
Vekemans M.... Aoun M.
|31|Compound heterozygosity for two MSH6 mutations in a patient with early onset of HNPCC-associated cancers, but without hematological malignancy and brain tumor. (16418736)
Plaschke J.... Schackert H.K.
|32|Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy. (16877725)
Razzouk B.I.... Rackoff W.R.
|33|Patient-rated emotional and physical functioning among hematologic cancer patients during hospitalization for stem-cell transplantation. (15580279)
Prieto J.M.... GastA^ C.
|34|Impact of five prophylactic filgrastim schedules on hematologic toxicity in early breast cancer patients treated with epirubicin and cyclophosphamide. (16129844)
Papaldo P.... Calabresi F.
|35|The spermatozoa protein, SLLP1, is a novel cancer-testis antigen in hematologic malignancies. (15475442)
Wang Z.... Lim S.H.
|36|In vitro chemosensitivity testing of hematological cancer patients: detection of ornithine decarboxylase. (12528799)
Bachrach U.... Wang Y.
|37|Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. (12351606)
Rizzo J.D.... Gordon M.S.
|38|Report of the fifteenth international symposium of the foundation for promotion of cancer research: new horizons in the diagnosis and treatment of hematological malignancies based on molecular genetic features. (12417606)
Multani P.S.... Sugimura T.
|39|Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. (12239138)
Rizzo J.D.... .
|40|Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. (11919251)
Prieto J.M.... GastA^ C.
|41|Hematological recovery and peripheral blood progenitor cell mobilization after induction chemotherapy and GM-CSF plus G-CSF in breast cancer. (10745254)
Charrier S.... Chassagne J.
|42|Acute hematologic feasibility of G-CSF supported dose-escalated FEC therapy as adjuvant treatment after breast cancer surgery. (10650787)
Ottosson S.... Hultborn R.
|43|Bropirimine (U-54461S) early phase II clinical studies--to investigate the efficacy and safety of bropirimine treatment on various malignant tumors (urological, hematologic, and dermal cancers)]. (9020948)
Furue H.... Ikeda S.
|44|Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses. (7537799)
Fennelly D.... Hoskins W.
|45|Effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on hematologic toxicity induced by high-dose chemotherapy in patients with metastatic breast cancer. (7492381)
Hansen F.... Skovsgaard T.
|46|Phase I trial of a 90-minute infusion of the fusion toxin DAB486IL-2 in hematological cancers. (8358720)
Lemaistre C.F.... Woodworth T.
|47|Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. (2185337)
Gianni A.M.... Bonadonna G.
|48|Autologous bone marrow transplantation for hematologic cancer. (2236163)
|49|Alzheimer's disease and senile dementia: genetic relationships to Down's syndrome and hematologic cancer. (154163)
|50|Albinism: hematologic-storage disease, susceptibility to skin cancer, and optic neuronal defects shared in all types of oculocutaneous and ocular albinism. (546241)